Gsk Plc Stock Annual Yield
| G1SK34 Stock | BRL 41.07 0.29 0.71% |
GSK plc fundamentals help investors to digest information that contributes to GSK Plc's financial success or failures. It also enables traders to predict the movement of GSK Stock. The fundamental analysis module provides a way to measure GSK Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GSK Plc stock.
GSK |
GSK plc Company Annual Yield Analysis
GSK Plc's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current GSK Plc Annual Yield | 0.04 % |
Most of GSK Plc's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GSK plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, GSK plc has an Annual Yield of 0.0411%. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-General industry. The annual yield for all Brazil stocks is notably lower than that of the firm.
GSK Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GSK Plc's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GSK Plc could also be used in its relative valuation, which is a method of valuing GSK Plc by comparing valuation metrics of similar companies.GSK Plc is currently under evaluation in annual yield category among its peers.
GSK Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.0659 | |||
| Profit Margin | 0.51 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 484.56 B | |||
| Shares Outstanding | 4.09 B | |||
| Price To Book | 2.60 X | |||
| Price To Sales | 9.93 X | |||
| Revenue | 34.11 B | |||
| Gross Profit | 19.92 B | |||
| EBITDA | 8.6 B | |||
| Net Income | 4.38 B | |||
| Total Debt | 19.76 B | |||
| Book Value Per Share | 5.25 X | |||
| Cash Flow From Operations | 7.95 B | |||
| Earnings Per Share | 6.69 X | |||
| Price To Earnings To Growth | 0.45 X | |||
| Number Of Employees | 10 | |||
| Beta | 0.28 | |||
| Market Capitalization | 388.07 B | |||
| Total Asset | 79.1 B | |||
| Z Score | 11.4 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 79.1 B | |||
| Last Dividend Paid | 0.61 |
About GSK Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GSK plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GSK Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GSK plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GSK Stock
GSK Plc financial ratios help investors to determine whether GSK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.